Advanced search
Publication Cover
Vascular Health and Risk Management Volume 3, 2007 - Issue 5
Submit an article Journal homepage
56
Views
5
CrossRef citations to date
0
Altmetric
Review

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation

Paolo Gelosa1 Department of Pharmacological Sciences, University of MilanItaly
,
Mauro Cimino2 Institute of Pharmacological Sciences, Carlo Bo University of UrbinoItaly
,
Alice Pignieri1 Department of Pharmacological Sciences, University of MilanItaly
,
Elena Tremoli1 Department of Pharmacological Sciences, University of MilanItaly;3 Monzino Cardiologic Center IRCCSMilan, Italy
,
Uliano Guerrini1 Department of Pharmacological Sciences, University of MilanItaly
&
Luigi Sironi1 Department of Pharmacological Sciences, University of MilanItalyCorrespondence[email protected]
Pages 567-577 | Published online: 28 Dec 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Kamil Mehmet Burgazli, Mark Andre Behrendt, Meric Mericliler, Ritvan Chasan, Mariana Parahuleva & Ali Erdogan. (2014) The Impact of Statins on FGF–2—Stimulated Human Umbilical Vein Endothelial Cells. Postgraduate Medicine 126:1, pages 118-128.
Read now
Frank H. Mose, Thomas Larsen, Janni M. Jensen, Annebirthe B. Hansen, Jesper N. Bech & Erling B. Pedersen. (2014) Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 74:1, pages 8-19.
Read now
Walter J Lukiw. (2012) Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer’s disease (AD). Expert Opinion on Emerging Drugs 17:1, pages 43-60.
Read now
Masamichi Yoshika, Yutaka Komiyama, Midori Masuda, Toyohiko Yokoi, Hiroya Masaki, Hiroe Ohkura & Hakuo Takahashi. (2010) Pitavastatin Further Decreases Serum High-Sensitive C-Reactive Protein Levels in Hypertensive Patients with Hypercholesterolemia Treated with Angiotensin II, Type-1 Receptor Antagonists. Clinical and Experimental Hypertension 32:6, pages 341-346.
Read now
Walter J Lukiw. (2008) Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD). Expert Opinion on Emerging Drugs 13:2, pages 255-271.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.